World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
78739
World Ranking
3160
National Ranking
1745

James A. de Lemos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James A. de Lemos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 771 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James A. de Lemos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James A. de Lemos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James A. de Lemos is affiliated with The University of Texas Southwestern Medical Center in the United States. Their work is concentrated primarily in the field of Medicine, with a significant focus on Cardiology and Cardiovascular Medicine. Their research portfolio includes over 505 publications, with 212 of these specifically related to cardiology and cardiovascular studies.

The scientist's research covers several subfields and main topics, including:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Infectious Diseases
  • Radiology, Nuclear Medicine and Imaging
  • Oncology

  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Blood Pressure and Hypertension Studies
  • Heart Failure Treatment and Management
  • COVID-19 Clinical Research Studies
  • Cardiac Imaging and Diagnostics
  • COVID-19 and healthcare impacts

De Lemos's frequent publication venues include some of the leading journals in cardiovascular and medical research such as:

  • Circulation
  • Journal of the American College of Cardiology
  • Journal of the American Heart Association
  • The American Journal of Cardiology
  • JAMA Cardiology

They have collaborated extensively with a number of researchers, with frequent co-authors including:

  • Christie M. Ballantyne
  • Colby Ayers
  • Jarett D. Berry
  • Vijay Nambi
  • Ambarish Pandey

Selected recent papers authored or co-authored by James A. de Lemos include:

  • "Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality" (2023), published in New England Journal of Medicine
  • "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19" (2020), published in Circulation
  • "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines" (2025), published in Circulation
  • "Myocarditis Temporally Associated With COVID-19 Vaccination" (2021), published in Circulation
  • "Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis" (2022), published in Circulation

Best Publications

  • 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

    Patrick T. O'Gara;Frederick G. Kushner;Deborah D. Ascheim;Donald E. Casey

  • 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Patrick T. O'Gara;Frederick G. Kushner;Deborah D. Ascheim;Donald E. Casey

  • 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

    Patrick T. O'Gara;Frederick G. Kushner;Deborah D. Ascheim;Donald E. Casey

  • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

    James A. de Lemos;David A. Morrow;Jane H. Bentley;Torbjørn Omland

  • TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.

    David A. Morrow;Elliott M. Antman;Andrew Charlesworth;Richard Cairns

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

    James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • B-type natriuretic peptide in cardiovascular disease

    James A de Lemos;Darren K McGuire;Mark H Drazner

  • HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

    Anand K Rohatgi;Amit Khera;Jarett D Berry;Edward G. Givens

  • Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population

    James A de Lemos;Mark H Drazner;Torbjorn Omland;Colby R. Ayers

  • A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

    Torbjørn Omland;James A de Lemos;Marc S. Sabatine;Costas A. Christophi

  • Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

    Marc S. Sabatine;David A. Morrow;James A. de Lemos;C. Michael Gibson

  • Race and gender differences in C-reactive protein levels.

    Amit Khera;Darren K. McGuire;Sabina A. Murphy;Harold G. Stanek

  • Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

    Justin T. Saunders;Justin T. Saunders;Vijay Nambi;James A. de Lemos;Lloyd E. Chambless

  • Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults

    Christopher R. deFilippi;James A. de Lemos;Robert H. Christenson;John S. Gottdiener

  • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions.

    Patrick T. O'Gara;Frederick G. Kushner;Deborah D. Ascheim;Donald E. Casey

  • Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults

    Ian J. Neeland;Aslan T. Turer;Colby R. Ayers;Tiffany M. Powell-Wiley

  • 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

    Glenn N. Levine;Eric R. Bates;James C. Blankenship;Steven R. Bailey

  • Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.

    James McCord;Hani Jneid;Judd E. Hollander;James A. de Lemos

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    David Preiss;Sreenivasa Rao Kondapally;Paul Welsh;Sabina A. Murphy

Frequent Co-Authors

Amit Khera
Amit Khera Harvard University
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
David A. Morrow
David A. Morrow Brigham and Women's Hospital
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Mark H. Drazner
Mark H. Drazner The University of Texas Southwestern Medical Center
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Elliott M. Antman
Elliott M. Antman Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to diverse healthcare careers, and there are various online degree options that can accelerate your path. If you are already a registered nurse, consider a cheapest rn to bsn program online to earn your Bachelor of Science in Nursing quickly and affordably. These programs can boost your qualifications while fitting around your schedule.

For those from non-nursing backgrounds wanting to join the nursing profession, direct entry msn programs for non nurses online provide a fast-track to becoming a registered nurse with a master's degree. They are ideal for those seeking career change into healthcare without starting from scratch.

If entry barriers are a concern, explore easiest nursing schools to get into that offer more flexible admissions criteria, helping you start your medical journey sooner.

Not all healthcare careers require direct patient care. For those interested in administrative roles, consider online medical billing and coding with financial aid programs. These accredited courses offer an accessible entry point into the medical field with strong job prospects and minimal upfront costs.

Best Scientists Citing James A. de Lemos

Trending Scientists

Recently Published Articles